Tag: mpa solution

Sproxil’s Ashifi Gogo Presenting at World Economic Forum Annual Meeting

FOR IMMEDIATE RELEASE 

Sproxil’s Ashifi Gogo Presenting at World Economic Forum Annual Meeting

Social Entrepreneur Recipient Examines Business Role In Addressing Societal Issues

AshifiGogo-WEF-quote

Cambridge, Mass. (January 19, 2015) – Sproxil®, Inc., a leading provider of world-class brand protection, is proud to announce Founder and CEO Ashifi Gogo has been selected to present at the 45th World Economic Forum Annual Meeting in Davos-Klosters, Switzerland this week.  Dr. Gogo will be one of five featured speakers in the highly anticipated Open Forum Session “Should Business Lead the Social Agenda” slated for Friday, January 23, 18:30 – 20:00.   The prestigious invitation to participate in the Annual Meeting is due in part to the Schwab Foundation recognizing Dr. Gogo as one of 37 recipients of the 2014 Social Entrepreneur of the Year honor.

According to the Meeting syllabus, the Open Forum Dr. Gogo is participating in examines how “Businesses play an increasingly important role in the global system, and face growing pressure from millennial consumers and employees to align core operations with social impact. Can businesses help to find a solution to global challenges, and should these challenges really be tackled by businesses?”

Dr. Gogo is the primary inventor of Sproxil’s flagship solution, Mobile Product Authentication™ (MPA™), which allows consumers to verify that products they buy are genuine by using a mobile phone and a simple, free text message. The solution uses a scratch card method, similar to that used for replenishing cellular talk-time. This allows users to reveal a one-time-use code on products and text the code to a call center phone number. A response is dispatched from Sproxil, indicating whether the product is genuine, potentially fake, or stolen.

Leading pharmaceutical companies, such as Johnson & Johnson, Merck, Serono, IPCA as well as regulatory organizations in the emerging markets of Africa and India have been leveraging the MPA solution to protect consumers from taking potentially harmful counterfeit and substandard medications since the company launched in 2009.  To date, the MPA solution has been used more than 14 million times to verify that products are genuine.

The MPA solution can be used to verify any tangible item, and Sproxil’s solution is currently being implemented and used for products across multiple industries including skin care, supplements and vitamins, electrical cabling, automotive and motorcycle parts and agro-business, to name a few.

Over 40 heads of state and government, as well as 2,500 other leaders from business and society will convene at the World Economic Forum Annual Meeting to discuss The New Global Context.

“It’s an honor to be invited to participate in the Open Forum discussion about the critical role businesses play in the Social Agenda, as well as being recognized as a Social Entrepreneur, joining a list of recipients that are dedicated to making positive, powerful differences in the world,” states Dr. Gogo. “It not only recognizes Sproxil’s work to combat counterfeit products, but also helps us gain recognition beyond the countries we currently operate in, so we can have a greater impact in regions most vulnerable to counterfeiting.”

“Each year the Davos Meeting brings together top political and business leaders from around the world to address critical global challenges. I am honored to join the dialogue,” he continued.

 

Contact:

Jeff Loucks, PR Manager, Sproxil

jeff.loucks@sproxil.com

+1 (781) 571-9330

 

Drug Anti-Counterfeiting Technology Reaches 1 Million Uses

FOR IMMEDIATE RELEASEContact:
Jennifer Viera
pr@sproxil.com

Consumers Use Sproxil’s MPA™ Solution to Determine Drug Safety More Than 1 Million Times in Battle Against Counterfeit Drugs
– User Base Expected to Grow in Response to Nigeria’s Malaria Epidemic and India’s New Directorate General of Foreign Trade Guidelines –

Cambridge, MA, January 25, 2012 – Sproxil, a leading provider of world-class brand protection for emerging markets, announced today that consumers within regions of Africa have used its Mobile Product Authentication™(MPA) technology more than one million times to verify their medication. Leading pharmaceutical companies and regulatory organizations in these regions have been leveraging Sproxil’s MPA solution since the company launched to protect consumers from taking potentially harmful counterfeit and substandard drugs.

“Knowing that consumers have used our technology more than one million times to validate their medication demonstrates both the simplicity of our solution, as well as the immense demand for it. Consumers no longer judge the authenticity of their product by its appearance; they verify it,” states Dr. Ashifi Gogo, Chief Executive Officer of Sproxil. He adds, “With support from regulatory authorities such as the National Agency for Food and Drug Administration and Control (NAFDAC) in Nigeria and the Pharmacy and Poisons Board in Kenya, Sproxil has grown significantly in a short period.”

Sproxil’s MPA solution is user friendly as is evidenced by its accelerated adoption. Upon purchasing medication, consumers scratch a label which reveals a one-time use code. They then text the code to a secure number provided on the package. As part of Sproxil’s MPA technology, the text message is processed to determine the drug’s genuineness. Within seconds, Sproxil notifies the end user, via text, of the result. Alternatively, consumers can call Sproxil’s consumer support desk to get results in their local language.

According to Director General of NAFDAC, Dr. Paul Orhii, NAFDAC’s use of Sproxil’s solution “puts the power of detection of counterfeits in the hands of millions of Nigerian consumers, thereby enlisting them in the war against counterfeiting.”
Demand for Sproxil’s MPA technology has grown despite the recent turmoil in Nigeria. Even in the wake of strikes in Nigeria, consumers remain concerned about receiving genuine medication and have still sent thousands of text messages to the company daily for drug verification. Not only is Sproxil’s technology being used despite this crisis, the need for it is only expected to intensify, as the presence of counterfeit and substandard drugs meant to control malaria is threatening millions of lives in Africa. Additionally, in India the Directorate General of Foreign Trade (DGFT) recently issued new guidelines for importing and exporting goods. Implementing India’s new policies could be simplified by using a technology such as Sproxil’s MPA.

About Sproxil
Sproxil is a venture-backed, social enterprise that provides world-class brand protection services in emerging markets. Through the company’s Mobile Product Authentication™ (MPA) solution, brand owners can connect with their customers in a way not previously achieved, by helping to ensure the goods they purchase are not stolen or counterfeit. Sproxil’s patent-pending product verification service allows individuals to text message a single-use item-specific code found on products using MPA technology, and receive a rapid response confirming the product’s genuineness or alerting the consumer to report incidents of suspicious activity to the brand owner. Sproxil’s solution is compatible with any tangible item, and it is already widely used by leading pharmaceutical companies to curb the multi-billion dollar counterfeit drug industry. Recognized as innovative and instrumental in the battle against counterfeiting, Sproxil has won the IBM SmartCamp Boston Award and the 2009 Clinton Global Initiative Outstanding Commitment Award, as well as received regulatory endorsements from the National Agency for Food and Drug Administration and Control in Nigeria and the Pharmacy and Poisons Board in Kenya. The company is headquartered in Cambridge, Massachusetts, United States and continues to expand its presence in multiple countries across Asia and Africa. For more information, please visit www.sproxil.com.